KERAGELT- dressing, wound, drug
MOLECULAR BIOLOGICALS, LLC
----------
keragelT® is a keratin enriched gel category dressing utilizing keratin technology to create and maintain a moist wound environment. It is presented sterile in a tube for ease of application.
keragelT® is designed for acute/chronic superficial and partial thickness wounds with dry to medium exudate, such as:
If the wound is infected, it is advised that you consult with your physician or health care professional.
The wound should be inspected daily or as indicated by a physician. For wounds that appear dry more gel should be applied to the area.
Keratin, phenoxyethanol, hydroxyethylcellulose, glycerol, sorbitol, propylene glycol, lactic acid.
keragelT® 20gm individual tube: | NDC 71474-302-20 |
keragelT® 5gm individual tube: | NDC 71474-302-05 |
keragelT® should be stored in dry conditions between 0° and 35°C (32° and 95° F).
Do not use if the tube has been damaged prior to use.
Sterility is guaranteed until the tube is first opened.
Do not re-sterilise.
CAUTION: RX ONLY. Federal law restricts this device to sale by or on the order of a physician.
Manufactured for: Molecular Biologicals, LLC
Pasadena, TX 77505 | 1-844-793-9933
EC | REP |
Keraplast Research Limited, Gerald St., Lincoln 7674, NZ
Medical Device Consultancy, 7 Pinewood Drive, Ashley Heath,
Market Drayton, Shropshire TF9 4PA, United Kingdom
keragelT® is a registered trademark of
Keraplast Technologies LLC.
The product incorporates patented and/or patent pending
technologies owned by Keraplast Technologies LLC.
Issue Date 9/2017
DWG107/1
KERAGELT
dressing, wound, drug |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - MOLECULAR BIOLOGICALS, LLC (079518915) |